Profarma Distribuidora Valuation
| PFRM3 Stock | BRL 7.07 0.10 1.39% |
At this time, the company appears to be overvalued. Profarma Distribuidora holds a recent Real Value of R$6.77 per share. The prevailing price of the company is R$7.07. Our model determines the value of Profarma Distribuidora from analyzing the company fundamentals such as Operating Margin of 0.03 %, return on equity of 0.0645, and Shares Outstanding of 122.61 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Profarma Distribuidora's price fluctuation is somewhat reliable at this time. Calculation of the real value of Profarma Distribuidora is based on 3 months time horizon. Increasing Profarma Distribuidora's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Profarma stock is determined by what a typical buyer is willing to pay for full or partial control of Profarma Distribuidora de. Since Profarma Distribuidora is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Profarma Stock. However, Profarma Distribuidora's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.07 | Real 6.77 | Hype 7.07 | Naive 6.74 |
The intrinsic value of Profarma Distribuidora's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Profarma Distribuidora's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Profarma Distribuidora de helps investors to forecast how Profarma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Profarma Distribuidora more accurately as focusing exclusively on Profarma Distribuidora's fundamentals will not take into account other important factors: Profarma Distribuidora Total Value Analysis
Profarma Distribuidora de is at this time projected to have takeover price of 1.35 B with market capitalization of 399.71 M, debt of 740.04 M, and cash on hands of 139.49 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Profarma Distribuidora fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.35 B | 399.71 M | 740.04 M | 139.49 M |
Profarma Distribuidora Investor Information
About 66.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Profarma Distribuidora last dividend was issued on the 21st of December 2022. The entity had 855:818 split on the 11th of January 2018. Based on the key measurements obtained from Profarma Distribuidora's financial statements, Profarma Distribuidora de is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Profarma Distribuidora Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Profarma Distribuidora has an asset utilization ratio of 159.02 percent. This implies that the Company is making R$1.59 for each dollar of assets. An increasing asset utilization means that Profarma Distribuidora de is more efficient with each dollar of assets it utilizes for everyday operations.Profarma Distribuidora Ownership Allocation
Profarma Distribuidora owns a total of 122.61 Million outstanding shares. Profarma Distribuidora holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.17 pct. of Profarma Distribuidora outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Profarma Distribuidora Profitability Analysis
The company reported the revenue of 6.41 B. Net Income was 78.19 M with profit before overhead, payroll, taxes, and interest of 907.57 M.About Profarma Distribuidora Valuation
The stock valuation mechanism determines Profarma Distribuidora's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Profarma Distribuidora based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Profarma Distribuidora. We calculate exposure to Profarma Distribuidora's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Profarma Distribuidora's related companies.Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people.
8 Steps to conduct Profarma Distribuidora's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Profarma Distribuidora's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Profarma Distribuidora's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Profarma Distribuidora's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Profarma Distribuidora's revenue streams: Identify Profarma Distribuidora's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Profarma Distribuidora's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Profarma Distribuidora's growth potential: Evaluate Profarma Distribuidora's management, business model, and growth potential.
- Determine Profarma Distribuidora's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Profarma Distribuidora's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Profarma Stock Analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.